No Data
No Data
Cybin Inc. Advances in Mental Health Treatments
CCORF Maintains Cybin(CYBN.US) With Buy Rating, Maintains Target Price $86
Optimistic Buy Rating for Cybin: Promising CYB003 Phase 2 Results and Market Potential
Express News | HC Wainwright & Co. Reiterates Buy on Cybin, Maintains $190 Price Target
Sector Update: Health Care Stocks Mixed Premarket Monday
Cybin Says Phase 2 Data Show Potential Depression Drug Offers Relief Through 1 Year
No Data
No Data
DazzlerAus Shatavia Eskdrige077 : I've been following this guy for a while just be clear he is not at all positive in DTJ for longer haul he fix a post election collapse is on the cards
Mr Trecherous OP DazzlerAus :